Shanghai North Carolina passed the "Little Giant" annual acceptance
Release time:
2020-08-14
Shanghai North Carolina Passed "Little Giant" Annual Acceptance
News Recently, Shanghai North Carolina Pharmaceutical Technology Co., Ltd., a new member of Jianfeng Pharmaceutical Co., Ltd., successfully passed the annual acceptance of Shanghai Science and Technology "Little Giant" Cultivation Enterprise.
In order to promote the independent innovation of enterprises, improve the core competitiveness of enterprises, enhance the competitive advantages of enterprises in domestic and foreign industries, and accelerate the construction of scientific and technological innovation, Shanghai North Carolina 2016 declared the Shanghai "Science and Technology Innovation Action Plan" science and technology "Little Giant" cultivation project and was approved, becoming a member of Shanghai's 87 "Little Giant" cultivation enterprises in that year, the project execution period is 2 years.
During the period of the Little Giant Cultivation Project, North Carolina completed the re-identification of Shanghai High-tech Enterprises and the identification of Songjiang District Enterprise Technology Center. Songjiang District Enterprise Technology Center was evaluated as excellent, passed the certification of Shanghai Academician Expert Workstation, passed the acceptance of Shanghai Patent Work Pilot Enterprises, and obtained a total of 4 invention patents authorized and 12 invention patents applied, registered trademarks 2 items, formulated enterprise standards 4 items, product testing reports 22 items, 2017 Songjiang District Industry-University-Research Innovation Project was approved and the project target was completed. Tinib drugs and their intermediates of
non-small cell lung cancer (NSCLC ) are the dominant varieties in North Carolina. In order to improve the existing tinib product line and consolidate the economic benefits and market share of this kind of products, North Carolina has carried out research and development on the latest generation of precision medicine special effect drugs such as cabozantinib (Cabozantinib) , ceritinib (Ceritinib ) and other kinds of API intermediates for tinib star varieties which are hot spots in the clinical research and development of generic drugs, also focus on the development of palbociclib (Palbociclib ) and gefitinib and other varieties of intermediate production process industrialization pilot and scale-up, and in-depth quality research and factory industrialization practice. In addition, North Carolina has also vigorously expanded the industrialization of the anti-diabetic drug pioglitazone, as well as the development of other products such as the endogenous active substance Paricalcitol, and carried out product layout for future development.
During the cultivation project period, North Carolina completed various tasks such as the optimization and construction of the innovation environment, the construction of the research and development team, and the research and development of scientific research projects, and carried out the upgrading and transformation of the research and development laboratory and pilot test platform, EIA filing and supporting environmental protection treatment facilities. 3# In mid-June, the Shanghai Municipal Science and Technology Commission launched the acceptance and evaluation of Shanghai's "Little Giant" enterprises. 12 enterprises recommended by the Songjiang District Science and Technology Commission participated in the defense. Kang Litao, general manager of Shanghai North Carolina, Li Qian, deputy general manager, and heads of R & D, finance and other departments participated in the on-site defense and successfully passed the defense acceptance. (Yang Shiqiong)
More information
Peak re-listed China's top 100 cement production capacity Daye peak won the "smart factory leader"
On July 11-12, the 2022 China Cement Industry Summit and TOP100 Award Ceremony organized by China Cement Network, an authoritative media of China's cement industry, was held in Hangzhou. Jianfeng Group once again ranked among the top 100 cement clinker production capacity in China.
2022
08-04
On the afternoon of July 12, the party Committee of the group company held a special meeting attended by party Committee members, senior and middle-level management backbones, heads of grass-roots party organizations and all party members of the group headquarters to learn and convey the spirit of the 15th party congress of the communist party of China in Zhejiang province.
2022
07-24
On the morning of July 1, more than 40 members of the group's party committee, party members of various branches of the group headquarters, and party members of subordinate enterprise branches went to the Shuanglong Hydropower Station, the Red Education Base of Jinhua City, to receive party spirit and revolutionary tradition education.
2022
07-14
Vocational skill level identification examination!
On June 16 and 18, the theoretical and practical examinations for the determination of professional skill level in the peak pharmaceutical sector were held successively in Jinxi pharmaceutical factory. The independent identification of vocational skill level includes three occupations (types of work): pharmaceutical preparation worker, chemical inspector and organic synthesis worker, basically covering the main posts in the pharmaceutical sector, with a total of 125 employees signing up for the identification.
2022
06-21
On June 16, the Jianfeng Pharmaceutical Quality Research and Development Party Branch and the Jinhua Vocational Skills Management Service Center Party Branch held a signing ceremony in Jinxi Factory to establish a party building alliance.
2022
06-21
Jinhua Mayor Xing Zhihong to Peak Research
On the afternoon of June 1, Jinhua Mayor Xing Zhihong, Wucheng District Party Committee Secretary Gao Feng, District Mayor Hu Yuxian, and heads of the Municipal Economic and Information Bureau, Development and Reform Bureau and other departments went to the group headquarters to discuss and exchange with the leaders of the group company to understand the development of the enterprise. Solicit opinions and suggestions from enterprises on government work. After understanding the current business situation of the peak, Xing Zhihong pointed out that focus, follow the right path, frontier, steady, is the peak to long-term prosperity of the magic weapon, must continue to adhere.
2022
06-13
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page